Bridgeway Capital Management’s Lexeo Therapeutics LXEO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$215K	Buy	53,400 +15,000	+39%	+$60.3K	0.01%	946
2025 Q1	$133K	Sell	38,400 -26,600	-41%	-$92.3K	﹤0.01%	993
2024 Q4	$428K	Buy	+65,000	New	+$428K	0.01%	849